You are here

Article info

Article menu

Download PDFPDF

Rheumatoid arthritis
Review
Biosimilars in rheumatology: what the clinician should know

Authors

  • Gilberto Castañeda-Hernández Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, Distrito Federal, MexicoCentro Latino Americano de Pesquisa em Biológicos, Rio de Janeiro, Brazil PubMed articlesGoogle scholar articles
  • Rodrigo González-Ramírez Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, Distrito Federal, Mexico PubMed articlesGoogle scholar articles
  • Jonathan Kay Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Morton A Scheinberg Hospital AACD, São Paulo, São Paulo, BrazilHospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Gilberto Castañeda-Hernández; gcastane{at}cinvestav.mx
View Full Text

Citation

Castañeda-Hernández G, González-Ramírez R, Kay J, et al
Biosimilars in rheumatology: what the clinician should know
RMD Open 2015;1:e000010. doi: 10.1136/rmdopen-2014-000010

Publication history

  • Received November 28, 2014
  • Revision received April 20, 2015
  • Accepted April 21, 2015
  • First published May 23, 2015.
Online issue publication 
May 23, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/